NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)
Ontology highlight
ABSTRACT: The purpose of this trial is to assess the tolerability and safety of NB1011 in the treatment of patients with cancers that overexpress TS, such as ovarian, gastrointestinal, colorectal, bladder, breast, and lung cancers.
DISEASE(S): Ovarian Cancer,Lung Cancer,Colorectal Cancer,Breast Cancer,Tumors
PROVIDER: 2023123 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA